The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Managing utilization growth of high-cost brand products with potential for off-label use helped minimize spend in some of the faster-growing drug categories like migraine and diabetes, says a new report.